Nusinersen Efficacy in Adults with Spinal Muscular Atrophy

被引：0
|
作者：
Day, John [1 ]
Wolford, Connie [2 ]
MacPherson, Chelsea [4 ]
Martens, William [5 ]
McDermott, Michael [6 ]
Darras, Basil [7 ]
De Vivo, Daryl [8 ]
Cunningham, Zarazuela Zolkipli [9 ]
Finkel, Richard [10 ]
Sampson, Jacinda [3 ]
Duong, Tina [1 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Neurol, Stanford, CA 94305 USA
[3] Stanford Univ, Fremont, CA USA
[4] Stanford Healthcare, Rehabil, Stanford, CA USA
[5] Univ Rochester, Rochester, NY USA
[6] Rochester Univ, Rochester, NY USA
[7] Harvard Med Sch, Childrens Hosp Boston, Boston, MA USA
[8] Columbia Univ, Neurol, Boston, MA USA
[9] Childrens Hosp Philadelphia, Neurol, Philadelphia, PA 19104 USA
[10] Nemours Childrens Hosp, Orlando, FL USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S46.001
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy
    Bahadir Senol, Hueseyin
    Yildiz, Gizem
    Polat, Ayse Ipek
    Aydin, Adem
    Hiz, Ayse Semra
    Soylu, Alper
    Yis, Uluc
    BRAIN AND BEHAVIOR, 2025, 15 (01):
  • [32] A multidisciplinary approach to dosing nusinersen for spinal muscular atrophy
    Zingariello, Carla D.
    Brandsema, John
    Drum, Elizabeth
    Henderson, Alicia A.
    Dubow, Scott
    Glanzman, Allan M.
    Mayer, Oscar
    Yum, Sabrina W.
    Kichula, Elizabeth A.
    NEUROLOGY-CLINICAL PRACTICE, 2019, 9 (05) : 424 - 432
  • [33] Objective and Subjective impact of Nusinersen in Spinal Muscular Atrophy
    Rodriguez Alvarez-Cienfuegos, J.
    Monton Alvarez, F. I.
    Gutierrez Martinez, A.
    Fregel Rodriguez, C.
    Diez, J. Aleman
    Claverie, I. Hernandez-Rojo
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 872 - 872
  • [34] Nusinersen treatment of spinal muscular atrophy - a systematic review
    Albrechtsen, Simon Sander
    Born, Alfred Peter
    Boesen, Magnus Spangsberg
    DANISH MEDICAL JOURNAL, 2020, 67 (09):
  • [35] Children with spinal muscular atrophy treated with nusinersen/risdiplam
    Chacko, A.
    Sly, P.
    Deegan, S.
    Young, E.
    Gauld, L.
    RESPIROLOGY, 2023, 28 : 204 - 205
  • [36] Nusinersen in infants with spinal Muscular Atrophy: Effective, but not curative
    Drexelius, Nina
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 (03) : 143 - 143
  • [37] OUTCOMES IN SPINAL MUSCULAR ATROPHY INFANTS ON NUSINERSEN THERAPY
    Kaltman, Joshua
    Verma, Sumit
    MUSCLE & NERVE, 2019, 60 : S7 - S7
  • [38] Performance fatigability in adults with spinal muscular atrophy treated long-term with nusinersen
    Stolte, Benjamin
    Neuhoff, Svenja
    Lipka, Jaqueline
    Schlag, Melina
    von Velsen, Otgonzul
    Kruse, Teresa
    Deuschl, Cornelius
    Kleinschnitz, Christoph
    Hagenacker, Tim
    MUSCLE & NERVE, 2024, 70 (06) : 1223 - 1229
  • [39] Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen
    Arnold, W. David
    Severyn, Steven
    Zhao, Songzhu
    Kline, David
    Linsenmayer, Matthew
    Kelly, Kristina
    Tellez, Marco
    Bartlett, Amy
    Heintzman, Sarah
    Reynolds, Jerry
    Sterling, Gary
    Weaver, Tristan
    Rajneesh, Kiran
    Burghes, Arthur H. M.
    Kolb, Stephen J.
    Elsheikh, Bakri
    BMJ NEUROLOGY OPEN, 2021, 3 (02)
  • [40] Children With Spinal Muscular Atrophy Treated With Nusinersen/Risdiplam
    Chacko, A.
    Sly, P. D.
    Deegan, S.
    Young, E.
    Gauld, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345